FDA To Providers: Do Not Withhold Medication-Assisted Opioid Addiction Treatment Due To Potential Interactions

FDA is updating its existing warnings on the dangers of combining addiction medications and certain anxiety and insomnia drugs to emphasize that despite the potential for potentially deadly interactions, medication-assisted treatment (MAT) for opioid addiction should not be withheld from patients already taking these anxiety medications. Instead, providers should develop a treatment plan that closely monitors any concomitant use of the drugs, FDA says. The agency announced Wednesday that it is updating both the existing boxed warnings for the drugs...